SSTR3 agonist-1 (TFA)
SSTR3 agonist-1 TFA is a potent, orally active, and selective SSTR3 agnoist (EC50 =0.14 nM) . SSTR3 agonist-1 TFA binds to SSTR3 receptor to inhibit cAMP activity. SSTR3 agonist-1 TFA decreases kidney weight and kidney cystic index (KCI) in a mouse model of autosomal dominant polycystic kidney disease (ADPKD) . SSTR3 agonist-1 TFA can be used for ADPKD research[1].
Product Specifications
UNSPSC
12352005
Target
Somatostatin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Purity
98.86
Smiles
O=C(C1=C(N=C2C=C(C(OC)=CC2=C1N3CC[C@H](C)NCC3)C(F)(F)F)N4CCOCC4)N[C@@H](C)C5=CC(OC)=C(F)C=C5.O=C(O)C(F)(F)F
Molecular Formula
C33H38F7N5O6
Molecular Weight
733.67
References & Citations
[1]Kim S. H., et al. Somatostatin Subtype Receptor 3 (SSTR3) Agonists and Uses Thereof. WO2025111318A1. 2025-05-30.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SSTR3
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
HSPA12A, ID (HSPA12A, KIAA0417, Heat shock 70kD protein 12A) (MaxLight 750) discontinued
Mouse Monoclonal IL-1 RAcP/IL-1 R3 Antibody (89412) [Janelia Fluor 525]